Tridien Medical acquired by Hill-Rom unit | Becton Dickinson to invest $100M in Neb. facility expansion | Canon invests $40M in T2 Biosystems
September 23, 2016
ADVAMED SmartBrief
News for medical technology professionals
Top Story
Tridien Medical acquired by Hill-Rom unit
All outstanding shares of Tridien Medical, a maker of patient positioning devices and support surfaces, have been acquired by Hill-Rom subsidiary Comfort Holdings, according to a regulatory filing. The companies did not disclose terms of the transaction.
Seeking Alpha (free registration) (9/22) 
LinkedIn Twitter Facebook Google+ Email
Business & Market Trends
Becton Dickinson to invest $100M in Neb. facility expansion
Becton Dickinson has committed to investing $100 million in its Holdrege, Neb., factory, which manufactures syringes for insulin. The company will upgrade the facility to boost production capacity, said company spokesman Troy Kirkpatrick.
Omaha World-Herald (Neb.) (9/22) 
LinkedIn Twitter Facebook Google+ Email
Canon invests $40M in T2 Biosystems
Canon USA has acquired a 19.9% stake in T2 Biosystems for $40 million. T2 CEO John McDonough said the financing will support the company's expansion and the launch of the T2Bacteria bacterial sepsis panel.
GenomeWeb Daily News (free registration) (9/22) 
LinkedIn Twitter Facebook Google+ Email
GE, Trice Imaging reach cloud-based ultrasound partnership
A partnership has been reached by GE Healthcare and Trice Imaging to integrate Trice's Tricefy cloud-based image sharing software into the women's health ultrasound offerings of GE, including the ViewPoint 6 reporting software and the Voluson E series scanners. Tricefy provides one-click ultrasound sharing and secure archiving for improving collaboration among physicians. (free registration) (9/22) 
LinkedIn Twitter Facebook Google+ Email
Science & Health
Data show positive results for Medtronic's drug-coated balloon
Data from two studies presented at the Vascular Interventional Advances annual conference showed positive results for Medtronic's In.Pact Admiral drug-coated balloon in treating claudication and restenosis in patients with superficial femoral artery disease. Use of the device indicated superior long-term clinical benefit, higher primary patency rates and lower clinically driven target lesion revascularization rates compared with plain balloon angioplasty. (Boston) (9/22) 
LinkedIn Twitter Facebook Google+ Email
Emerging Technologies
LivaNova announces US launch of next-gen ICDs, CRT-Ds
The Platinium implantable cardiac defibrillators and cardiac resynchronization therapy devices have been launched by UK-based LivaNova in the US. The next-generation devices, which have low energy consumption and enhanced longevity, come with the Parad+ arrhythmia discrimination algorithm and SafeR pacing mode for natural heart conduction preservation. (Boston) (9/22) 
LinkedIn Twitter Facebook Google+ Email
Becton Dickinson debuts wireless diagnostic device
The BD Veritor Plus System, a wireless diagnostic device that detects influenza A and B, group A strep and respiratory syncytial virus in minutes, has been launched by Becton Dickinson. The device allows for wireless data transmission to laboratory information or EMR systems and ensures accurate traceability through documentation of user ID, test kit lot number and specimen ID. (9/22) 
LinkedIn Twitter Facebook Google+ Email
Government & Regulatory
Canada OKs Staar Surgical's intraocular lenses
Health Canada's Medical Devices Bureau has given Monrovia, Calif.-based Staar Surgical approval for its EVO Visian Toric ICL intraocular lenses, which are intended to be implanted between the iris and the eye's natural lens to treat myopia and astigmatism. (Boston) (9/22) 
LinkedIn Twitter Facebook Google+ Email
FDA clears next-gen mobility tracker from Global Kinetics
Australia-based Global Kinetics has obtained 510(k) clearance from the FDA for its PKG Watch, an upgraded version of its Parkinson's KinetiGraph mobility tracker. The smartwatch-like device, which is more compact and smaller than the earlier version, is intended to provide precise monitoring, quantifying and reporting of movement symptoms in patients with neurological diseases, such as Parkinson's disease. (9/22), (9/22) 
LinkedIn Twitter Facebook Google+ Email
AdvaMed Events and Education
Reimbursement 101: A Primer on Medical Device Reimbursement
Sept. 27-28 | Washington, D.C.
During this workshop, you will be provided with the road map and practical applications to successfully navigate the many potential reimbursement pitfalls. After an overview of current reimbursement issues, you'll hear from industry veterans and reimbursement professionals who will discuss case studies and real-life scenarios. Learn more.
LinkedIn Twitter Facebook Google+ Email
Reimbursement 201: A Deeper Dive into the Reimbursement Landscape
Sept. 28-29 | Washington, D.C.
This next-level reimbursement workshop was created with the more advanced professional in mind. You'll walk away from this workshop with more insight into the complex and critical nature of coverage issues and policy. Learn more.
LinkedIn Twitter Facebook Google+ Email
Learn more about AdvaMed:
About AdvaMed | Join | Courses | Events | Newsroom
powered by
R&D Engineer
Director Franchise HEMA, Specialty Solutions
Quality Risk Manager
TERUMO BCT - Lakewood, CO
Whatever you want in life, other people are going to want too. Believe in yourself enough to accept the idea that you have an equal right to it.
Diane Sawyer,
LinkedIn Twitter Facebook Google+ Email
Sign Up
SmartBrief offers 200+ newsletters
Learn more about the SmartBrief audience
Subscriber Tools:
Contact Us:
Advertising  -  Meryl Harold
P: 202.407.7828
Jobs Contact  -
Editor  -  Lisa Gough
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
© 1999-2016 SmartBrief, Inc.®
Privacy policy |  Legal Information